PE anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_PE_021606
C57BL/6 mouse splenocytes stained with 17A2 PE
  • 17A2_PE_021606
    C57BL/6 mouse splenocytes stained with 17A2 PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
100205 50 µg 49€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100206 200 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Pedraza-Zamora C, et al. 2017. Parasite Immunol. 10.1111/pim.12420. PubMed
  2. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  3. Ushijima M, et al. 2018. Front Immunol. 9:243. PubMed
  4. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  5. Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed
  6. Huang L, et al. 2018. Exp Neurol. 300:41. PubMed
  7. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  8. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  9. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  10. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  11. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  12. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  13. Shen S, et al. 2018. Pain Med. 19:686. PubMed
  14. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  15. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  16. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  17. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  18. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  19. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  20. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  21. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  22. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  23. Lin H, et al. 2019. Infect Immun. 87:e00055-19. PubMed
  24. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  25. Biram A, et al. 2020. Cell Rep. 30:1910. PubMed
  26. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  27. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  28. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
  29. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  30. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  31. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  32. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  33. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  34. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  35. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  36. Ding Y, et al. 2020. Evid Based Complement Alternat Med. 2020:9521073. PubMed
  37. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  38. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  39. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  40. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  41. Zhang T, et al. 2020. Cell. 180(6):1115-1129. PubMed
  42. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  43. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  44. Fathman J, et al. 2010. Proc Natl Acad Sci U S A. 107:3663. PubMed
  45. Bedi B, et al. 2012. Proc Natl Acad Sci U S A. 109:275. PubMed
  46. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  47. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  48. Schneider A, et al. 2014. J Leukoc Biol. 96:857. PubMed
  49. Rozanski C, et al. 2015. J Immunol. 194:4717. PubMed
  50. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  51. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  52. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  53. Zuchtriegel G, et al. 2016. PLoS Biol. 14: 1002459. PubMed
  54. Reboldi A, et al. 2016. Sci Transl Med. 352: aaf4822. PubMed
  55. Schmidt D, et al. 2016. PLoS One. 11: 0159059. PubMed
  56. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  57. Yamamura K, et al. 2017. Nat Commun. 8:13946. PubMed
  58. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  59. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  60. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  61. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  62. Lewandowski JP, et al. 2020. Genome Biol. 1.039583333. PubMed
  63. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  64. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  65. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  66. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  67. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  68. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  69. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  70. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  71. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  72. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  73. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  74. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  75. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  76. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  77. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  78. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  79. Zeng F, et al. 2021. J Invest Dermatol. 596:141. PubMed
  80. Wu J, et al. 2020. Immunity. 53:115. PubMed
  81. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  82. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  83. Kuang Z, et al. 2020. Antib Ther. 3:227. PubMed
  84. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  85. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  86. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  87. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  88. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  89. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  90. Cho K, et al. 2021. iScience. 24:103117. PubMed
  91. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  92. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  93. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  94. Goldman E, et al. 2021. Cells. 10:. PubMed
  95. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  96. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  97. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  98. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  99. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  100. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  101. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  102. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  103. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  104. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  105. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  106. Zhou Y, et al. 2022. Nat Commun. 13:2906. PubMed
  107. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  108. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  109. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  110. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  111. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  112. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  113. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  114. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  115. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  116. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  117. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  118. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  119. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  120. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  121. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  122. Gawish R, et al. 2022. Elife. 11:. PubMed
  123. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  124. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  125. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  126. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  127. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  128. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  129. Al-Rifai R, et al. 2022. Nat Commun. 13:6592. PubMed
  130. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  131. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  132. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  133. Hiyoshi H, et al. 2022. Cell Host Microbe. 30:163. PubMed
  134. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  135. Wang D, et al. 2022. Cell Rep. 39:110587. PubMed
  136. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  137. Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed
  138. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  139. TaSli PN, et al. 2022. J Food Biochem. 46:e14393. PubMed
  140. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  141. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  142. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  143. Domingos-Pereira S, et al. 2022. Int J Mol Sci. 24: . PubMed
  144. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  145. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  146. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  147. Zhao L, et al. 2022. Oncogene. 41:4200. PubMed
  148. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  149. Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed
  150. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  151. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  152. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  153. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  154. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  155. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  156. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  157. Milighetti M, et al. 2023. iScience. 26:106937. PubMed
RRID
AB_312662 (BioLegend Cat. No. 100205)
AB_312663 (BioLegend Cat. No. 100206)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11.30.2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account